Mumbai: ZenOnco.io,an integrative oncology healthtech platform,has received global recognition at the European Society
for Medical Oncology (ESMO) Annual Virtual Congress, held last month, for introducing the world’s first artificial intelligence-based tool to generate directional cancer treatment assessment reports free of charge. The platform provides artificial intelligence-based directional cancer treatment assessment reports free of cost to patients to guide them on possible treatment options, covering both medical as well as complementary treatment approaches. “Being recognised globally at the ESMO Annual Virtual Congress 2020 is a testimony to our dedication to making quality integrative cancer care accessible to all,” Kishan Shah, cofounder of ZenOnco.io said.
Oncology Healthtech Platform Receives Global Recognition
